Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. The Group’s main products are contrast agents sold in over 100 countries, both directly and indirectly through branches, joint ventures and license and distribution agreements.
We are looking for an Energy Asset & Project Manager to join the Energy Management team.
The Energy Asset & project Manager will manage the regulatory aspects and performance of existing and planned energy generation assets, with a particular focus on cogeneration and photovoltaic plants, as well as initiatives aimed at renewable energy generation and energy resilience. The role will also be responsible for identifying optimisation and efficiency improvement opportunities.
The position requires a combination of technical, financial, contractual and organisational expertise, together with the ability to coordinate internal stakeholders, suppliers, consultants, ESCOs, grid operators and external authorities.
The role requires approximately 30–40% travel.
The role is classified at Level A under the Italian National Collective Agreement for the Chemical-Pharmaceutical Industry (CCNL Chimico-Farmaceutico). The guaranteed minimum annual gross salary established by the CCNL for the applicable level is €46,518.36.
The compensation package also includes an annual variable incentive linked to the achievement of company and individual objectives, as well as the benefits provided for by the applicable collective agreement and company policies. The overall package will be defined on the basis of objective, gender-neutral criteria, such as relevant professional experience and the skills required for the role.
Permanent
If you meet the requirements of this opportunity and would like to join an international group working to improve patients' lives, apply now!
At Bracco, we believe in the values of diversity and inclusion. We respect and celebrate the diversity of our people and their experiences, ensuring a fair opportunity for all.
Bracco is an international Group active in the healthcare sector and a leader in diagnostic imaging. It has around 3,700 employees and annual total consolidated revenues of around 1,7 billion euros, 89% of which from international sales. In the R&D area, the company invests approximately 10% of reference turnover in the imaging diagnostics and medical devices sectors. The Group’s main products are contrast agents, medical substances used to improve the diagnostic accuracy of biomedical imaging and the care of patients affected by diseases of varying type and severity. Bracco offers an extensive and innovative portfolio of products and solutions for all diagnostic modalities completed by several medical devices and advanced administration systems for contrast imaging products in the fields of cardiology and radiology, developed by it’s American company ACIST. Since its foundation, Bracco has been a socially responsible company in each area of activity - in business as in every other context. Its subsidiary Bracco Imaging is one of the world’s leading companies in the diagnostic imaging field :X-Ray Imaging (including Computed Tomography-CT), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound, and Nuclear Medicine. The Company operates in over 110 markets: in North America through Bracco Diagnostics Inc. USA , and with an affiliate in Montreal (Canada); in Europe, with offices in all major countries; in Japan (BRACCO-EISAI). The Company also operates in South America, South Korea and China through its 70% controlled Joint Venture, Bracco Sine Pharmaceutical Corp. Ltd.
